SCHEMBL5043319

SCHEMBL5043319

CCO[C@H](C(=O)NCc1ccc(C#N)cc1)c1c(F)cc(-c2ccccc2OCCOCc2ccccc2)cc1F

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
PDE10A Q9Y233 7/20 0.37
PTGES O14684 1/20 0.36
F10 P00742 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN9A Q15858 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
CNR2 P34972 1/20 0.36
HTR1A P08908 3/20 0.35
DRD2 P14416 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5043316 1.00 ALDH1A1 (0.37) ALDH1A1KDM4ENPC1MAPTHPGD
SCHEMBL5041453 0.88 KDM4E (0.42) ALDH1A1KDM4EPDE10AF10LMNA
SCHEMBL5041460 0.88 KDM4E (0.42) ALDH1A1KDM4EPDE10AF10LMNA
Hydrochloric Acid SCHEMBL5038113 0.86 F10 (0.49) F10
Hydrochloric Acid SCHEMBL5038105 0.86 F10 (0.49) F10
SCHEMBL5045213 0.84 CNR2 (0.38) ALDH1A1SLC1A3SLC1A2F10SCN5A
SCHEMBL5041913 0.84 F10 (0.45) RAB9ASLC1A3SLC1A2F10SCN5A
SCHEMBL5045218 0.84 CNR2 (0.38) ALDH1A1SLC1A3SLC1A2F10SCN5A
SCHEMBL5041919 0.84 F10 (0.45) RAB9ASLC1A3SLC1A2F10SCN5A
SCHEMBL5037965 0.84 SLC1A3 (0.42) SLC1A3SLC1A2SCN5ASCN9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885KDM4E 2563/4885NPC1 3616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.